Your team

Meet the Team Behind This Evidence Review

Four physicians staff the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Dr. Ke He is the responsible physician for this evidence review; the Center Director guarantees the standards the practice is held to, and the team carries the assessment of skin quality and the reversible options that usually come first.

Specialist profiles

Who reviews this content

Ke He

Ke He (何锞)

Deputy Director & Head of Skin & Laser Aesthetics · Attending Physician, Licensed Aesthetic Attending · Lead Physician of This Site

Collagen-stimulating injectables and their limits · nodule risk and site selection · reversibility and the reversible options first

Dr. Ke He is Deputy Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital and head of its skin and laser aesthetic service — and she is the lead physician of this site. A core specialist formerly at the Plastic and Aesthetic Surgery Department of Xinqiao Hospital, affiliated with Army Medical University, she has worked on the clinical front line in skin laser and injectable aesthetics for more than 20 years, serving over ten thousand patients.

On this review his part is the distinction between a tissue finding and a visible result. He describes histology as evidence that something happened in the tissue, not as a forecast of how much anyone will see, and he separates the named indication from the general cosmetic use it is often cited to support. Because nothing reverses these materials, he starts the conversation with what cannot be undone and works back from there, considers the reversible options first where a change is wanted, and describes the risk of lumps with the sites where it is highest rather than as a general caution. Where a result would not be worth the permanence, he says so instead of describing the treatment as gradual and safe.

Clinical focus

  • What the tissue response does and does not establish about a visible result
  • The named indication behind a material, and the off-label uses beside it
  • Reversibility, and why a decision that cannot be undone is discussed first
  • Nodule risk and site selection, including areas where the skin is thin
  • The reversible options, where a change is wanted and permanence is not required

Academic roles & achievements

  • Member, Laser Medicine Group, Chinese Medical Association Plastic Surgery Branch
  • Member, Facial Rejuvenation Group, Chinese Medical Association Plastic Surgery Branch
  • Member, Chongqing Plastic Surgery Quality Control Center
  • Published 5 papers, holds 5 national patents, and introduced 2 new clinical techniques

Nothing here can be injected away

A hyaluronic acid filler can be dissolved, which makes an unwanted result a problem that can be addressed. These materials cannot, and that difference changes what a decision about them is: not a trial of a change, but a commitment to one. That is why the reversible options are described first on this site.

Shaoliang Wang

Shaoliang Wang (王韶亮)

Director, Plastic Surgery & Aesthetics Medical Center · Vice Chief Physician, Associate Professor, Doctor of Medicine

Center leadership and multidisciplinary case review

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

Within the team, Shaoliang Wang contributes to the shared assessment of cases on this site.

Clinical focus

  • Center leadership and multidisciplinary case review
  • Surgical assessment when an operation is the honest answer to descent or excess skin
  • Hospital-based care for the rare complication that needs theatre-level management
Tongchun Mao

Tongchun Mao (毛彤春)

Deputy Director & Head of Aesthetic Surgery · Vice Chief Physician, Licensed Aesthetic Attending

Aesthetic surgical assessment and refinement of contour and asymmetry

Dr. Tongchun Mao is an aesthetic surgeon within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is refinement and honest referral: he is the person who says so when an operation will do better than an injectable or a device.

Within the team, Tongchun Mao contributes to the shared assessment of cases on this site.

Clinical focus

  • Aesthetic surgical assessment and refinement of contour and asymmetry
  • Honest referral when surgery outperforms a course of injections
  • Shared case planning within the four-physician team
Yongbo Jia

Yongbo Jia (贾勇波)

Deputy Director & Head of Dermatology · Vice Chief Physician, Licensed Aesthetic Attending

Medical skin assessment behind injectable treatment plans

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Within the team, Yongbo Jia contributes to the shared assessment of cases on this site.

Clinical focus

  • Medical skin assessment behind injectable treatment plans
  • Diagnosis and management of pigment and barrier conditions
  • Dermatologic care of skin after irritation or a delayed reaction

A question about the collagen stimulation evidence?

This site is an evidence review rather than a booking page. It does not recommend for or against a treatment, and it does not offer an assessment or a consultation in relation to anything it describes. If you have a question about this review, or about your own care, contact the team and ask.

Contact the Team